Viewing Study NCT00083005


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2026-02-21 @ 4:35 PM
Study NCT ID: NCT00083005
Status: COMPLETED
Last Update Posted: 2012-03-15
First Post: 2004-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None recurrent prostate cancer View
None stage IV prostate cancer View